Evidence map›Paper›PMID 38760892›Full record

ArticleClinical and translational medicine2024

Serum exosomal tsRNA biomarkers: A novel strategy for identifying lupus nephritis.

Ping Yang, Yifan Sun, Chenlan Wang, Zhibo Li, Yiyuan Han, Jianming Gong, Adeel Khan, Jin Wang, Yanbo Wang, Fangfang Jin and 1 more

Abstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. PeerJ · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ping YangDepartment of Clinical Laboratory, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.ORCID 0000-0003-3495-856X
Yifan SunDepartment of Clinical Laboratory, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Chenlan WangState Key Laboratory of Pharmaceutical Biotechnology, Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, NJU Advanced Institute of Life Sciences, Nanjing University, Nanjing, China.
Zhibo LiJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Yiyuan HanJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Jianming GongDepartment of Clinical Laboratory, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Adeel KhanDepartment of Biotechnology, University of Science and Technology, Bannu, Pakistan.
Jin WangState Key Laboratory of Pharmaceutical Biotechnology, Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, NJU Advanced Institute of Life Sciences, Nanjing University, Nanjing, China.
Yanbo WangState Key Laboratory of Pharmaceutical Biotechnology, Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, School of Life Sciences, NJU Advanced Institute of Life Sciences, Nanjing University, Nanjing, China.
Fangfang JinJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Zhiyang LiDepartment of Clinical Laboratory, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

Funding

Nanjing Drum Tower Hospital Clinical Research Special Fund Project 2022-LCYJ-PY-36Nanjing Drum Tower Hospital Clinical Research Special Fund Project 2023-LCYJ-MS-13National Natural Science Foundation of China 82003024National Natural Science Foundation of China 82202600Natural Science Foundation of Jiangsu Province BK2020041989Natural Science Foundation of Nanjing University of Chinese Medicine NZY82003024Qing Lan Project
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersExosomesLupus NephritisFemaleHumansRNABiomarkersRNA

Identifiers

PMID38760892
PMCPMC11101668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.